NeoGraph Analytics
Medical DevicesNorth America2023 – 2032

Minimally Invasive Surgery Market Size, Share and Trends Analysis

Global minimally invasive surgery market size reached $48.2B in 2023, projected to grow at 5.6% CAGR to $79.5B by 2032. Explore key trends, regional analysis, and leading players.

Revenue, 2023

$48.2B

Forecast, 2032

$79.5B

CAGR, 2024-2032

5.6%

Report Coverage

North America

Code: minimally-invasive-surgery-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Market Overview

The global minimally invasive surgery market is experiencing robust growth, driven by technological advancements and increasing adoption across diverse surgical specialties. With a projected CAGR of 5.6%, the market is anticipated to expand from $48.2 billion in 2023 to $79.5 billion by 2032.

Market Stage

High growth

Adoption Level

Early mainstream

Key Trends

Integration of artificial intelligence for real-time surgical guidanceRising adoption of robotic-assisted platforms in developing economiesIncreasing focus on single-port laparoscopic systemsGrowth in ambulatory surgery centers utilizing MIS technologies
02

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 5.6%

Base Year (2023)

$49.8B

Forecast (2032)

$79.5B

CAGR (2024-2032)

5.6%

Regional Market Analysis
Market share and growth rate by region

North America

#1
Share: 45.3%CAGR: 5.9%

Largest market: United States

Europe

#2
Share: 28.1%CAGR: 5.2%

Largest market: Germany

03

Market Dynamics

  • Aging global population increasing demand for complex surgical procedures
  • Advancements in robotic surgery enabling new applications
  • Patient preference for reduced recovery times and lower complication rates
  • Government initiatives promoting value-based healthcare models
04

Market Segmentation

By Component

  • Surgical Instruments
  • Energy Devices
  • Imaging Systems
  • Robotics Platforms

By Application

  • General Surgery
  • Urology
  • Gynecology
  • Orthopedics
  • Cardiothoracic Surgery

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
05

Regional Analysis

1

North America

Lead: United States
CAGR: 5.9%Share: 45.3%

Dominates the global market due to high adoption of robotic systems and advanced healthcare infrastructure.

2

Europe

Lead: Germany
CAGR: 5.2%Share: 28.1%

Strong growth driven by EU MDR compliance and increasing reimbursement for MIS procedures.

3

Asia Pacific

Lead: China
CAGR: 7.8%Share: 22.4%

Fastest-growing region due to rising healthcare spending and expanding surgical volumes in emerging economies.

Country-Level Analysis

CountryShareGrowth
United States
32.7%
+5.7%
China
15.2%
+8.3%
Germany
9.1%
+5.1%
06

Competitive Landscape

I

Intuitive Surgical

United States

Leader12.1B

Dominates robotic surgery with da Vinci systems, focusing on AI integration and new surgical applications.

da Vinci SP SystemSurgical Planning AIReal-time Motion Tracking
S

Stryker Corporation

United States

Challenger11.3B

Strong in orthopedic robotics (Mako) and surgical imaging, expanding into AI-powered procedural planning.

Mako Robotic-Arm SystemAI Surgical Planning SuiteIntraoperative Imaging Analytics
M

Medtronic PLC

Ireland

Follower30.2B

Leaders in energy devices and laparoscopic instruments, with AI-driven surgical planning tools.

Harmless Electrosurgical DevicesAI-Powered Surgical PlanningSurgical Instrument Tracking
J

Johnson & Johnson

United States

Follower

Focuses on general surgery instruments and emerging robotic platforms through its Ethicon division.

S

Siemens Healthineers

Germany

Follower

Specializes in imaging and AI-driven surgical navigation systems for MIS procedures.

07

Recent Developments

25
2025Intuitive Surgical

Launched da Vinci 2.0 with real-time AI-powered tissue recognition for enhanced surgical precision.

25
2025Siemens Healthineers

Introduced AI-driven intraoperative navigation system for real-time surgical guidance.

24
2024Stryker

Acquired surgical AI startup for predictive analytics platform to integrate with Mako robotics.

24
2024Medtronic

Received FDA approval for AI-enhanced electrosurgical device reducing procedure time by 15%.

24
2024Johnson & Johnson

Partnered with AI company to develop surgical decision support tools for minimally invasive procedures.

08

Regulatory Landscape

FDA's SaMD (Software as a Medical Device) guidelines for AI-integrated surgical systemsEU MDR requirements for clinical evidence of robotic surgical devicesCMS reimbursement policies for robotic-assisted procedures in the USHIPAA compliance for data security in AI-powered surgical platforms
09

Frequently Asked Questions

The global minimally invasive surgery market was valued at $48.2 billion in 2023 and is projected to reach $79.5 billion by 2032.
The market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2032.
North America currently dominates the market with a 45.3% share, primarily driven by the United States.
Key growth drivers include the aging population increasing surgical demand, technological advancements in robotic systems, and patient preference for reduced recovery times.